Dr. Ronald Angelo Sismondo Jr., M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Ste 101, Wheeling, WV 26003 Phone: 304-231-2090 |
Derek Hugh Andreini, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park, Suite 703, Wheeling, WV 26003 Phone: 304-242-6373 Fax: 304-242-6371 |
Dr. Robert A Caveney, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2115 Chapline St, Ste 107, Wheeling, WV 26003 Phone: 304-243-1050 Fax: 304-243-0140 |
Mary Margaret Haus, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Eoff St, Suite 603, Wheeling, WV 26003 Phone: 304-234-3405 Fax: 304-234-3406 |
Robert J Zaleski, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 10 Medical Park Ste 203, Wheeling, WV 26003 Phone: 304-242-9460 Fax: 304-242-6958 |
Jeffrey Michael Abbott, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 Medical Park, Suite 206, Wheeling, WV 26003 Phone: 304-243-6534 Fax: 304-243-8575 |
News Archive
AIDS Healthcare Foundation today commended the United States Congress for showing a strong bipartisan commitment to AIDS in passing the fiscal year 2011 budget earlier this afternoon, a budget that despite severe cost-cutting mentality in Washington, included a $48 million overall increase in the $883 million allocated for the nation's AIDS Drug Assistance Program, a network of federal and state funded programs that provide life-saving HIV treatments to low income, uninsured, and underinsured individuals living with HIV/AIDS nationwide.
Young women who are treated for Hodgkin lymphoma with chest radiation therapy have a high cumulative absolute risk of developing breast cancer later in life. This risk increases with age at end of follow-up, time since diagnosis, and radiation dose, according to a new study in the October 5 issue of the Journal of the National Cancer Institute.
At the Institut Curie, CNRS and Inserm researchers have shown that cysteamine, which is already used to treat a rare disease called cystinosis, prevents the death of neurons in Huntington's disease. Like Alzheimer's and Parkinson's, Huntington's disease, is characterized by the abnormal death of neurons.
Based on the study of cell signalling networks, the cell signals that drugs alter when they reach their target molecule, an exhaustive in silico analysis of the pairing of 64 therapeutic agents used to treat breast cancer (half already in use and the other half in clinical testing phase) has allowed researchers at the Institute for Research in Biomedicine to identify 10 new and previously untested combinations that hold potential for the treatment of breast cancer.
› Verified 3 days ago